| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Regular Article |
a Department of Physiology and
b CESEX, School of Medicine, University of La Laguna, 38071 Tenerife, Spain
This study assessed whether the in vivo production of nitric oxide (NO) in the penis is impaired in experimental diabetes and whether this phenomenon can be explained by abnormal levels of NO synthase isoenzymes and/or plasma androgens. Adult male Sprague-Dawley rats were injected with streptozotocin (STZ) (40 mg/kg, i.p.) or vehicle. One half of the STZ-treated animals received daily insulin replacement. Twelve weeks later, the animals were tested for mating behavior and erectile reflexes. They were then anesthetized with urethane (1 g/kg), and the NO levels in their corpora cavernosa were monitored electrochemically with porphyrin microsensors before and after electrostimulation of the cavernous nerve. The intracavernous pressure (ICP) was measured simultaneously. The diabetic animals had substantial impairment in the mating and erectile reflexes tests, decreased basal and stimulated NO levels in the corpora, and a reduced ICP response to cavernous nerve stimulation. Insulin replacement fully reversed the effects of diabetes on the mating reflexes, the basal NO signals, and the ICP responses to electrical field stimulation and partially restored the stimulated NO release. Neither diabetes nor diabetes with insulin treatment had significant effects on serum testosterone levels or NOS isoform (nNOS, eNOS, and iNOS) protein content in penile homogenates, indicating that the changes found in erectile function were independent of such variables. These results also suggest that the diabetes-induced reduction in corporeal NO levels could be mainly due to the lack of some essential cofactors for NOS activity rather than to changes in the amount of enzyme proteins.
1 This work was supported by grant PM99-0144 from the Spanish Ministry of Science and Technology.
2 Correspondence: Manuel Mas, Departamento de Fisiología, Facultad de Medicina, Universidad de La Laguna, 38071 Tenerife, Spain. FAX: 34 922 319397; mmas{at}ull.es
This article has been cited by other articles:
|
|
 |
|
  H. Zheng, K. R. Bidasee, W. G. Mayhan, and K. P. Patel Lack of central nitric oxide triggers erectile dysfunction in diabetes Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1158 - R1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Agarwal, K. C. Nandipati, R. K. Sharma, C. D. Zippe, and R. Raina Role of Oxidative Stress in the Pathophysiological Mechanism of Erectile Dysfunction J Androl, May 1, 2006; 27(3): 335 - 347. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Musicki and A. L. Burnett eNOS Function and Dysfunction in the Penis Experimental Biology and Medicine, February 1, 2006; 231(2): 154 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Musicki, M. F. Kramer, R. E. Becker, and A. L. Burnett Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction PNAS, August 16, 2005; 102(33): 11870 - 11875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Rempel, B. R. Francis, K. J. Austin, and T. R. Hansen Isolation and Sequence of an Interferon-{tau}-Inducible, Pregnancy- and Bovine Interferon-Stimulated Gene Product 15 (ISG15)-Specific, Bovine Ubiquitin-Activating E1-Like (UBE1L) Enzyme Biol Reprod, February 1, 2005; 72(2): 365 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Brown, H. Wessells, M. B. Chancellor, S. S. Howards, W. E. Stamm, A. E. Stapleton, W. D. Steers, S. K. Van Den Eeden, and K. T. McVary Urologic Complications of Diabetes Diabetes Care, January 1, 2005; 28(1): 177 - 185. [Full Text] [PDF]
|
|
|
|
|
|
L. De Young, D. Yu, R. M. Bateman, and G. B. Brock Oxidative Stress and Antioxidant Therapy: Their Impact in Diabetes-Associated Erectile Dysfunction J Androl, September 1, 2004; 25(5): 830 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Bivalacqua, M. F. Usta, H. C. Champion, P. J. Kadowitz, and W. J. G. Hellstrom Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and Disease J Androl, November 1, 2003; 24(6_suppl): S17 - S37. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cellek, N. A. Foxwell, and S. Moncada Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats Diabetes, September 1, 2003; 52(9): 2353 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 213 - 225. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
